glp 1 and glp 2 drugs What is the Difference Between GLP-1, GLP-2, GLP-3? MCT2D | The Benefits of
Description
Plainsboro, NJ: Novo Nordisk Inc

Their onset can be avoided or the severity reduced to a large extent if dose escalation is performed as indicated in the label, and if, while treatment lasts, a series of well-defined dietary and behavioral recommendations are followed.66 In patients who observe these recommendations, the adverse effects may disappear in a few days or weeks.67 Arguments in favor of GLP-1 receptor agonists for weight control in patients with obesity and inflammatory dermatoses As mentioned earlier, weight loss has a positive effect on the outcome and response to treatments for PsO and HS
However, it is considered an important risk factor for weight gain (16, 17) ( Figure 1 )

Both drugs share the same dual-agonist mechanism